Cargando…

The Effect of Fluoxetine on Progression in Progressive Multiple Sclerosis: A Double-Blind, Randomized, Placebo-Controlled Trial

Preclinical studies suggest that fluoxetine may have neuroprotective properties. In this pilot study forty-two patients with secondary or primary progressive MS were randomized to receive fluoxetine 20 mg twice daily or placebo for 2 years. Every 3 months the Expanded Disability Status Scale (EDSS),...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mostert, Jop, Heersema, Thea, Mahajan, Manju, Van Der Grond, Jeroen, Van Buchem, Mark A., De Keyser, Jacques
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747490/ https://www.ncbi.nlm.nih.gov/pubmed/23984093 http://dx.doi.org/10.1155/2013/370943

Ejemplares similares

Tremor in multiple sclerosis
por: Koch, Marcus, et al.
Publicado: (2007)

Fluoxetine in Progressive Multiple Sclerosis (FLUOX-PMS): study protocol for a randomized controlled trial
por: Cambron, Melissa, et al.
Publicado: (2014)

MRI brain volume loss, lesion burden, and clinical outcome in secondary progressive multiple sclerosis
por: Koch, Marcus W, et al.
Publicado: (2021)

MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study
por: Tourbah, Ayman, et al.
Publicado: (2016)

COVID-19 in multiple sclerosis: The Dutch experience
por: Loonstra, Floor C, et al.
Publicado: (2020)

Efficacy of andrographolide in not active progressive multiple sclerosis: a prospective exploratory double-blind, parallel-group, randomized, placebo-controlled trial
por: Ciampi, Ethel, et al.
Publicado: (2020)

N,N-Dimethylglycine in patients with progressive multiple sclerosis: result of a pilot double-blind, placebo, controlled randomized clinical trial
por: Wolfsegger, Thomas, et al.
Publicado: (2021)

Kinetics of myelin breakdown products: A labeling study in patients with progressive multiple sclerosis
por: Kanhai, Kawita M. S., et al.
Publicado: (2021)

Randomized, double-blind, placebo-controlled trial of arimoclomol in rapidly progressive SOD1 ALS
por: Benatar, Michael, et al.
Publicado: (2018)

Efficacy of vitamin C as an adjunct to fluoxetine therapy in pediatric major depressive disorder: a randomized, double-blind, placebo-controlled pilot study
por: Amr, Mostafa, et al.
Publicado: (2013)

Fluoxetine for motor recovery after acute intracerebral hemorrhage (FMRICH): study protocol for a randomized, double-blind, placebo-controlled, multicenter trial
por: Marquez-Romero, Juan Manuel, et al.
Publicado: (2013)

Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis
por: Mandrioli, Jessica, et al.
Publicado: (2023)

Longitudinal Progression of Magnetic Resonance Imaging Markers and Cognition in Dutch-Type Hereditary Cerebral Amyloid Angiopathy
por: van Dijk, Suzanne E., et al.
Publicado: (2022)

CoQ10 in progressive supranuclear palsy: A randomized, placebo-controlled, double-blind trial
por: Apetauerova, Diana, et al.
Publicado: (2016)

Intravenous administration of adenosine triphosphate and phosphocreatine combined with fluoxetine in major depressive disorder: protocol for a randomized, double-blind, placebo-controlled pilot study
por: Chen, Yiyi, et al.
Publicado: (2019)

Individualized Homeopathic Treatment and Fluoxetine for Moderate to Severe Depression in Peri- and Postmenopausal Women (HOMDEP-MENOP Study): A Randomized, Double-Dummy, Double-Blind, Placebo-Controlled Trial
por: Macías-Cortés, Emma del Carmen, et al.
Publicado: (2015)

The MSIS-29 and SF-36 as outcomes in secondary progressive MS trials
por: Strijbis, Eva MM, et al.
Publicado: (2022)

Double-Blind Controlled Randomized Trial of Cyclophosphamide versus Methylprednisolone in Secondary Progressive Multiple Sclerosis
por: Brochet, Bruno, et al.
Publicado: (2017)

Impact of clinical outcomes and imaging measures on health-related quality of life in secondary progressive MS
por: W Koch, Marcus, et al.
Publicado: (2021)

Minocycline for sporadic and hereditary cerebral amyloid angiopathy (BATMAN): study protocol for a placebo-controlled randomized double-blind trial
por: Voigt, S., et al.
Publicado: (2023)

Confirmatory factor analysis of the Dutch Screening Visual Complaints questionnaire in people with multiple sclerosis
por: van der Feen, Fleur E., et al.
Publicado: (2022)

Correction: Individualized Homeopathic Treatment and Fluoxetine for Moderate to Severe Depression in Peri- and Postmenopausal Women (HOMDEP-MENOP Study): A Randomized, Double-Dummy, Double-Blind, Placebo-Controlled Trial
Publicado: (2015)

Retraction: Individualized Homeopathic Treatment and Fluoxetine for Moderate to Severe Depression in Peri- and Postmenopausal Women (HOMDEP-MENOP Study): A Randomized, Double-Dummy, Double-Blind, Placebo-Controlled Trial
Publicado: (2020)

Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis
por: Connick, Peter, et al.
Publicado: (2018)

Safety and acceptability of clozapine and risperidone in progressive multiple sclerosis: a phase I, randomised, blinded, placebo-controlled trial
por: La Flamme, Anne C, et al.
Publicado: (2020)

Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial
por: Chataway, Jeremy, et al.
Publicado: (2020)

Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial
por: Zajicek, John, et al.
Publicado: (2013)

Efficacy of individualized homeopathic treatment and fluoxetine for moderate to severe depression in peri- and postmenopausal women (HOMDEP-MENOP): study protocol for a randomized, double-dummy, double-blind, placebo-controlled trial
por: Macías-Cortés, Emma del Carmen, et al.
Publicado: (2013)

Efficacy and safety of adding fluoxetine to the treatment regimen of hospitalized patients with non‐critical COVID‐19 pneumonia: A double‐blind randomized, placebo‐controlled clinical trial
por: Sedighi, Faranak, et al.
Publicado: (2023)

Role of fluoxetine in pharmacological enhancement of motor functions in stroke patients: A randomized, placebo-controlled, single-blind trial
por: Krishnan, Karthickeyan, et al.
Publicado: (2021)

Atorvastatin for prevention of disease progression and hospitalisation in liver cirrhosis: protocol for a randomised, double-blind, placebo-controlled trial
por: Kimer, Nina, et al.
Publicado: (2020)

Oral levosimendan in amyotrophic lateral sclerosis: a phase II multicentre, randomised, double-blind, placebo-controlled trial
por: Al-Chalabi, Ammar, et al.
Publicado: (2019)

T Cell Vaccination Benefits Relapsing Progressive Multiple Sclerosis Patients: A Randomized, Double-Blind Clinical Trial
por: Karussis, Dimitrios, et al.
Publicado: (2012)

Selective Involvement of the Amygdala in Systemic Lupus Erythematosus
por: Emmer, Bart J, et al.
Publicado: (2006)

Nortriptyline versus fluoxetine in the treatment of major depressive disorder: a six-month, double-blind clinical trial
por: Hashemi, SN, et al.
Publicado: (2012)

Treatment of internuclear ophthalmoparesis in multiple sclerosis with fampridine: A randomized double‐blind, placebo‐controlled cross‐over trial
por: Kanhai, Kawita M. S., et al.
Publicado: (2019)

A Randomized, Double Blind, Placebo-Controlled Trial of Pioglitazone in Combination with Riluzole in Amyotrophic Lateral Sclerosis
por: Dupuis, Luc, et al.
Publicado: (2012)

Fecal microbiota transplantation in systemic sclerosis: A double-blind, placebo-controlled randomized pilot trial
por: Fretheim, Håvard, et al.
Publicado: (2020)

The metformin in tuberous sclerosis (MiTS) study: A randomised double-blind placebo-controlled trial
por: Amin, Sam, et al.
Publicado: (2021)

Effects of Metformin on the Regulation of Free Fatty Acids in Insulin Resistance: A Double-Blind, Placebo-Controlled Study
por: Castro Cabezas, Manuel, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_igt8sef7097kdm5d0n9rd6vrq1